Bensheim, Germany

Markus Karmatschek


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • 64625 Bensheim, DE (2010)
  • Bensheim, DE (2010 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Markus Karmatschek

Introduction

Markus Karmatschek is a notable inventor based in Bensheim, Germany. He has made significant contributions to the field of medical therapies, particularly in the treatment of tumors and their metastases. With a total of 3 patents to his name, Karmatschek's work is focused on innovative methods that target specific medical conditions.

Latest Patents

Karmatschek's latest patents include a method for treating tumors and their metastases. This invention relates to a therapy that specifically targets tumors that preferentially settle in bone tissue. The method involves administering an active ingredient that comprises at least one binding molecule that binds to human bone sialoprotein or a fragment thereof. Another significant patent is for a medicament designed to treat tumors and their metastases, which also focuses on those that settle in bone tissue. This medicament includes at least one binding molecule that binds to bone sialoprotein or a fragment thereof found in serum or plasma.

Career Highlights

Throughout his career, Karmatschek has worked with various companies, including Armbruster Biotechnology GmbH. His innovative approaches and dedication to medical research have positioned him as a key figure in his field.

Collaborations

Karmatschek has collaborated with notable individuals such as Franz Paul Armbruster and Mats Paulsson. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Markus Karmatschek's contributions to medical innovation, particularly in the treatment of tumors, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving therapeutic methods and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…